Krystal Biotech Inc (KRYS)
170.85
-5.54
(-3.14%)
USD |
NASDAQ |
Nov 04, 16:00
171.06
+0.21
(+0.12%)
After-Hours: 20:00
Krystal Biotech Total Assets (Quarterly): 917.66M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 917.66M |
| March 31, 2024 | 853.30M |
| December 31, 2023 | 818.36M |
| September 30, 2023 | 790.35M |
| June 30, 2023 | 684.03M |
| March 31, 2023 | 531.85M |
| December 31, 2022 | 558.45M |
| September 30, 2022 | 576.38M |
| June 30, 2022 | 601.32M |
| March 31, 2022 | 616.87M |
| December 31, 2021 | 626.30M |
| September 30, 2021 | 451.10M |
| June 30, 2021 | 443.56M |
| March 31, 2021 | 443.02M |
| December 31, 2020 | 310.84M |
| Date | Value |
|---|---|
| September 30, 2020 | 311.45M |
| June 30, 2020 | 318.14M |
| March 31, 2020 | 205.13M |
| December 31, 2019 | 209.02M |
| September 30, 2019 | 214.23M |
| June 30, 2019 | 205.16M |
| March 31, 2019 | 115.70M |
| December 31, 2018 | 116.12M |
| September 30, 2018 | 54.45M |
| June 30, 2018 | 46.03M |
| March 31, 2018 | 47.85M |
| December 31, 2017 | 50.11M |
| September 30, 2017 | 52.67M |
| June 30, 2017 | 3.977M |
| December 31, 2016 | 2.182M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
205.13M
Minimum
Mar 2020
917.66M
Maximum
Jun 2024
540.37M
Average
558.45M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Bioventus Inc | 792.17M |
| ADMA Biologics Inc | 376.40M |
| Axsome Therapeutics Inc | 548.23M |
| Amicus Therapeutics Inc | 749.48M |
| Sarepta Therapeutics Inc | 3.424B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 78.76M |
| Shareholders Equity (Quarterly) | 838.89M |
| Current Ratio | 9.503 |